Announcing SMi's 5th Annual event... For the 5th year running, SMi will bring together key experts in the field to provide a platform for networking and discussion A unique opportunity to learn from leading industry experts including: · Dr Alejandro Aruffo, President, Abbott Bioresearch Center, Abbott · Dr David Glover, Chief Medical Officer, Cambridge Antibody Technology · Dr Vivian Albert, Vice President, Preclinical Research & Development, Human Genome Sciences · Dr Joseph Bolen, Senior Vice President, Research & Drug Discovery, Millennium · Dr Lutz Jermutus, Director, Antibody Engineering, Cambridge Antibody Technology · Dr Eileen Elliott, Senior Director Immunology Biology, Pfizer · Dr René Hoet, Director, Research & Technology, Dyax · Dr Jane Osbourn, Vice President, Display Technology, Cambridge Antibody Technology · Dr Leon Hooftman, Head, Clinical Development, Celltech · Dr Simon Hufton, Director, Research & Technology, Dyax · Dr Thomas von Rueden, Executive Vice President, Business Development & Chief Scientific Officer, MorphoSys Hot topics to be covered at this event include: · MARKET TRENDS: Look at key trends and predictions to 2008: How can you capitalise on the ‘fully human wave?’ · ANTIBODY TECHNOLOGIES: Identify the latest developments in ribosome, yeast and phage display technologies · ONCOLOGY ANTIBODIES: Assess novel immunomodulatory approaches for cancer and hear about current projects from leading companies · SYNTHETIC THERAPEUTIC ANTIBODIES: Discover the application of structure-based design to therapeutic antibody development · CASE STUDIES: Meet leaders in the field and learn from their mixed experiences in oncology and other therapeutic areas including inflammatory and infectious diseases |